Skip to main content
Fig. 2 | Acta Neuropathologica Communications

Fig. 2

From: EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma

Fig. 2

Validation of selected BioID2-identified EMP3-proximal proteins using proximity ligation assay (PLA). PLA signals (magenta) indicating physical proximity (~ 40 nm) between EMP3 and various BioID2 hits, including EGFR, retromer components (TBC1D5, SNX1, SNX2), clathrin-coated vesicle-associated protein CLINT1 and EARP complex member VPS53. SOX2 was used as negative control. Nuclei are colored in cyan. Scale bar = 20 μm

Back to article page